# Tadalafil

## Cialis 5mg  \(28 tablets/box\)

| 藥物代碼 | OCIA5 |
| :--- | :--- |
| 適應症 | 1.Treatment of erectile dysfunction. 2.Treatment of the signs and symptoms of benign prostatic hyperplasia \(BPH\) |
| 副作用 | headache, dyspepsia, back pain, myalgia, nasopharyngitis, cough, or flushingCommon■Dermatologic: Flushing \(1% to 13% \)■Gastrointestinal: Indigestion \(1% to 13% \), Nausea \(up to 11% \)■Musculoskeletal: Backache \(2.4% to 12% \), Myalgia \(1% to 14% \)■Neurologic: Headache \(3% to 42% \)■Respiratory: Nasopharyngitis \(2% to 13% \), Respiratory tract infection \(3% to 13% \)Serious■Cardiovascular: Angina \(less than 2% \), Chest pain \(less than 2% \), Heart failure, Myocardial infarction \(less than 2% \), Tachycardia \(less than 2% \)■Dermatologic: Stevens-Johnson syndrome■Neurologic: Cerebral hemorrhage, Cerebrovascular accident, Seizure■Ophthalmic: Non-arteritic ischemic optic neuropathy, Retinal artery occlusion, Thrombosis of retinal vein■Otic: Decreased hearing, Sudden onset \(less than 2% \), Sudden hearing loss \(less than 2% \) |
| 禁忌 | 1.Concomitant use of nitrates \(any form\) either regularly or intermittently.2.Hypersensitivity to tadalafil; Stevens-Johnson syndrome and exfoliative dermatitis have been reported |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | Micromedex: Infant risk cannot be ruled out. \(1\)Available evidence and/or expert consensus is inconclusive or is inadequate for determining infant risk when used during breastfeeding. Weigh the potential benefits of drug treatment against potential risks before prescribing this drug during breastfeeding. \(2\)Clinical Management:Tadalafil is not indicated for use in women and there are no reports describing the use of tadalafil during human lactation availableThe effects on the nursing infant from exposure to the drug in milk are unknown. Tadalafil is secreted into the milk of lactating rats at approximately 2.4 times the concentration found in plasma. No information is available on the secretion of tadalafil into human breast milk. |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

